Hiroki Morizono

Predicting the severity of motor neuron disease progression using electronic health record data with a cloud computing Big Data approach

Tarek A. El-Ghazawi, Kyung Dae Ko, Dongkyu Kim, 2014, 2014 IEEE Conference on Computational Intelligence in Bioinformatics and Computational Biology.

Acetylornithine Transcarbamylase: a Novel Enzyme in Arginine Biosynthesis

Norma M. Allewell, Hiroki Morizono, D. Shi, 2006, Journal of bacteriology.

Crystal Structure of N-Acetylornithine Transcarbamylase from Xanthomonas campestris

Hiroki Morizono, D. Shi, H. Morizono, 2005, Journal of Biological Chemistry.

Baseline human gut microbiota profile in healthy people and standard reporting template

Konstantinos Krampis, Raja Mazumder, Keith A Crandall, 2018, bioRxiv.

Mutations and polymorphisms in the human ornithine transcarbamylase (OTC) gene

Hiroki Morizono, H. Morizono, M. Tuchman, 2006, Human mutation.

Crystal structure of a transcarbamylase-like protein from the anaerobic bacterium Bacteroides fragilis at 2.0 A resolution.

Hiroki Morizono, D. Shi, H. Morizono, 2002, Journal of molecular biology.

Enabling precision medicine via standard communication of HTS provenance, analysis, and results

Gil Alterovitz, Carole Goble, Stian Soiland-Reyes, 2017, bioRxiv.

Design and Implementation of the Hepatorenal Fibrocystic Disease Core Center Clinical Database: A Centralized Resource for Characterizing Autosomal Recessive Polycystic Kidney Disease and Other Hepatorenal Fibrocystic Diseases

Hiroki Morizono, Lisa M. Guay-Woodford, H. Morizono, 2017, Front. Pediatr..

A dual AAV system enables the Cas9-mediated correction of a metabolic liver disease in newborn mice

Yang Yang, Deirdre McMenamin, Peter Bell, 2016, Nature Biotechnology.

Structures of N‐acetylornithine transcarbamoylase from Xanthomonas campestris complexed with substrates and substrate analogs imply mechanisms for substrate binding and catalysis

Hiroki Morizono, D. Shi, H. Morizono, 2006, Proteins.